OPT•benzinga•
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty
Summary
Opthea's Phase 3 COAST trial for wet AMD did not meet its primary endpoint, raising financial concerns as the company faces potential investor obligations.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga